(Q36629558)

English

Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study

scientific article published on 27 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study (English)

1 reference

Europe PubMed Central

15 August 2017

type-1 diabetes

0 references

insulin glargine

1 reference

based on heuristic

inferred from title

Julio Rosenstock

1

object named as

Julio Rosenstock

1 reference

Europe PubMed Central

15 August 2017

Richard M Bergenstal

2

object named as

Richard M Bergenstal

1 reference

Europe PubMed Central

15 August 2017

author name string

Thomas C Blevins

3

1 reference

Europe PubMed Central

15 August 2017

Linda A Morrow

4

1 reference

Europe PubMed Central

15 August 2017

Melvin J Prince

5

1 reference

Europe PubMed Central

15 August 2017

Yongming Qu

6

1 reference

Europe PubMed Central

15 August 2017

Vikram P Sinha

7

1 reference

Europe PubMed Central

15 August 2017

Daniel C Howey

8

1 reference

Europe PubMed Central

15 August 2017

Scott J Jacober

9

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

27 November 2012

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

36

1 reference

Europe PubMed Central

15 August 2017

3

1 reference

Europe PubMed Central

15 August 2017

522-528

1 reference

Europe PubMed Central

15 August 2017

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

1 September 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579351

30 September 2017

Review article: Drug-induced liver injury--its pathophysiology and evolving diagnostic tools

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579351

30 September 2017

Drug-related hepatotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579351

30 September 2017

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579351

30 September 2017

Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579351

30 September 2017

Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579351

30 September 2017

Insulin analogues and their potential in the management of diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579351

30 September 2017

Banting's, Best's, and Collip's accounts of the discovery of insulin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579351

30 September 2017

Insulin Pharmacokinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579351

30 September 2017

A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579351

28 June 2018

Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579351

20 September 2018

THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS

1 reference

https://pubmed.ncbi.nlm.nih.gov/23193209

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin zinc suspension; four years' experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/23193209

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2337/DC12-0067

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36629558&oldid=1866118606"